http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8700180-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91fe1cddc99f9255118b5a663deed0fc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8574b1d13bdd20bb91351ece7186df09
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-3605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-0551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-36071
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05
filingDate 2012-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2c46c2cf28387517e5af8f67c7ad099
publicationDate 2014-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-8700180-B2
titleOfInvention Method for improving far-field activation in peripheral field nerve stimulation
abstract A method of providing therapy to a patient having a disorder using an electrode located adjacent a peripheral target neural region. The method comprises conveying electrical stimulation energy from the electrode that stimulates a first set of nerve endings in the peripheral target neural region. The method further comprises increasing an activation threshold of a second set of nerve endings in the peripheral target neural region, thereby rendering the second set of nerve endings less excitable to the electrical stimulation energy. The first set of nerve endings are relatively far from the electrode and the second set of nerve endings are relatively near the electrode.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10828491-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11446498-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11202909-B2
priorityDate 2011-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010016929-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005267546-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7539538-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003236558-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004015205-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7742810-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010324630-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466851716
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3676

Total number of triples: 28.